Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.
Bocanegra A, Fernández-Hinojal G, Ajona D, Blanco E, Zuazo M, Garnica M, Chocarro L, Alfaro-Arnedo E, Piñeiro-Hermida S, Morente P, Fernández L, Remirez A, Echaide M, Martinez-Aguillo M, Morilla I, Tavira B, Roncero A, Gotera C, Ventura A, Recalde N, Pichel JG, Lasarte JJ, Montuenga L, Vera R, Pio R, Escors D, Kochan G.
Bocanegra A, et al. Among authors: blanco e.
EMBO Rep. 2023 Aug 3;24(8):e55884. doi: 10.15252/embr.202255884. Epub 2023 Jun 27.
EMBO Rep. 2023.
PMID: 37366231
Free PMC article.